{"id":"https://openalex.org/W4205437420","doi":"https://doi.org/10.1007/s10557-021-07310-y","title":"Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany","display_name":"Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany","alternate_titles":[],"publication_year":2022,"publication_date":"2022-01-11","ids":{"openalex":"https://openalex.org/W4205437420","doi":"https://doi.org/10.1007/s10557-021-07310-y","pmid":"https://pubmed.ncbi.nlm.nih.gov/35015186","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10397126"},"language":"en","primary_location":{"id":"doi:10.1007/s10557-021-07310-y","doi":"https://doi.org/10.1007/s10557-021-07310-y","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10557-021-07310-y","pdf_url":"https://link.springer.com/content/pdf/10.1007/s10557-021-07310-y.pdf","source":{"id":"https://openalex.org/S131791641","display_name":"Cardiovascular Drugs and Therapy","issn_l":"0920-3206","issn":["0920-3206","1573-7241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Drugs and Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4205437420"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s10557-021-07310-y.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000839870","display_name":"Daniel Tobias Michaeli","orcid":"https://orcid.org/0000-0003-2913-1867","observed_orcids":["https://orcid.org/0000-0003-2913-1867"]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]},{"id":"https://openalex.org/I4210156450","display_name":"University Medical Centre Mannheim","ror":"https://ror.org/05sxbyd35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210156450"]}],"countries":["DE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Daniel Tobias Michaeli","raw_affiliation_strings":["Department of Personalized Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany. danielmichaeli@yahoo.com","Fifth Department of Medicine, University Hospital Mannheim, Heidelberg University, Mannheim, Germany. danielmichaeli@yahoo.com","Fifth Department of Medicine, University Hospital Mannheim, Heidelberg University, Mannheim, Germany"],"raw_orcid":"https://orcid.org/0000-0003-2913-1867","affiliations":[{"raw_affiliation_string":"Department of Personalized Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany. danielmichaeli@yahoo.com","institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4210156450"]},{"raw_affiliation_string":"Fifth Department of Medicine, University Hospital Mannheim, Heidelberg University, Mannheim, Germany. danielmichaeli@yahoo.com","institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4210156450"]},{"raw_affiliation_string":"Fifth Department of Medicine, University Hospital Mannheim, Heidelberg University, Mannheim, Germany","institution_ids":["https://openalex.org/I223822909"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033869278","display_name":"Julia Caroline Michaeli","orcid":"https://orcid.org/0000-0001-6484-7161","observed_orcids":["https://orcid.org/0000-0001-6484-7161"]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]},{"id":"https://openalex.org/I4210086161","display_name":"Asklepios Klinik Altona","ror":"https://ror.org/00pbgsg09","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210086161"]},{"id":"https://openalex.org/I4210160608","display_name":"Asklepios","ror":"https://ror.org/055tk9p53","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210160608"]},{"id":"https://openalex.org/I4210162578","display_name":"Asklepios Kliniken Hamburg","ror":"https://ror.org/05f8ejd38","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210162578"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Julia Caroline Michaeli","raw_affiliation_strings":["Department of Obstetrics and Gynecology, Asklepios-Clinic Hamburg Altona, Asklepios Hospital Group, Hamburg, Germany","Fifth Department of Medicine, University Hospital Mannheim, Heidelberg University, Mannheim, Germany"],"raw_orcid":"https://orcid.org/0000-0001-6484-7161","affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Asklepios-Clinic Hamburg Altona, Asklepios Hospital Group, Hamburg, Germany","institution_ids":["https://openalex.org/I4210086161","https://openalex.org/I4210160608","https://openalex.org/I4210162578"]},{"raw_affiliation_string":"Fifth Department of Medicine, University Hospital Mannheim, Heidelberg University, Mannheim, Germany","institution_ids":["https://openalex.org/I223822909"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074524521","display_name":"Tobias Boch","orcid":"https://orcid.org/0000-0001-8588-4180","observed_orcids":["https://orcid.org/0000-0001-8588-4180"]},"institutions":[{"id":"https://openalex.org/I17937529","display_name":"German Cancer Research Center","ror":"https://ror.org/04cdgtt98","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529"]},{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]},{"id":"https://openalex.org/I4210156450","display_name":"University Medical Centre Mannheim","ror":"https://ror.org/05sxbyd35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210156450"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tobias Boch","raw_affiliation_strings":["Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany","Department of Personalized Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany","Division of Personalized Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany"],"raw_orcid":"https://orcid.org/0000-0001-8588-4180","affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany","institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4210156450"]},{"raw_affiliation_string":"Department of Personalized Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany","institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4210156450"]},{"raw_affiliation_string":"Division of Personalized Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany","institution_ids":["https://openalex.org/I17937529"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018170393","display_name":"Thomas Michaeli","orcid":"https://orcid.org/0000-0003-0293-9401","observed_orcids":["https://orcid.org/0000-0003-0293-9401"]},"institutions":[{"id":"https://openalex.org/I17937529","display_name":"German Cancer Research Center","ror":"https://ror.org/04cdgtt98","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529"]},{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]},{"id":"https://openalex.org/I4210156450","display_name":"University Medical Centre Mannheim","ror":"https://ror.org/05sxbyd35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210156450"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas Michaeli","raw_affiliation_strings":["Department of Personalized Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany","Division of Personalized Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany","Fifth Department of Medicine, University Hospital Mannheim, Heidelberg University, Mannheim, Germany"],"raw_orcid":"https://orcid.org/0000-0003-0293-9401","affiliations":[{"raw_affiliation_string":"Department of Personalized Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany","institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4210156450"]},{"raw_affiliation_string":"Division of Personalized Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany","institution_ids":["https://openalex.org/I17937529"]},{"raw_affiliation_string":"Fifth Department of Medicine, University Hospital Mannheim, Heidelberg University, Mannheim, Germany","institution_ids":["https://openalex.org/I223822909"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5000839870"],"corresponding_institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4210156450"],"apc_list":{"value":3860,"currency":"USD","value_usd":3860},"apc_paid":{"value":3860,"currency":"USD","value_usd":3860},"fwci":3.3161,"has_fulltext":true,"cited_by_count":24,"citation_normalized_percentile":{"value":0.93762262,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"37","issue":"4","first_page":"683","last_page":"694"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.014600000344216824,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9459999799728394},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.9300000071525574},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.6769999861717224},{"id":"https://openalex.org/keywords/icosapent-ethyl","display_name":"icosapent ethyl","score":0.9380000233650208},{"id":"https://openalex.org/keywords/pcsk9-inhibitors","display_name":"PCSK9 inhibitors","score":0.968999981880188},{"id":"https://openalex.org/keywords/evolocumab","display_name":"evolocumab","score":0.972000002861023},{"id":"https://openalex.org/keywords/alirocumab","display_name":"alirocumab","score":1.0},{"id":"https://openalex.org/keywords/ezetimibe","display_name":"ezetimibe","score":0.9950000047683716},{"id":"https://openalex.org/keywords/fibrates","display_name":"fibrates","score":0.9089999794960022},{"id":"https://openalex.org/keywords/major-adverse-cardiovascular-events","display_name":"major adverse cardiovascular events","score":0.8040000200271606},{"id":"https://openalex.org/keywords/primary-prevention","display_name":"primary prevention","score":0.8370000123977661},{"id":"https://openalex.org/keywords/secondary-prevention","display_name":"secondary prevention","score":1.0},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.921999990940094},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.843999981880188},{"id":"https://openalex.org/keywords/markov-cohort-model","display_name":"Markov cohort model","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9542654752731323},{"id":"https://openalex.org/C2778657065","wikidata":"https://www.wikidata.org/wiki/Q417997","display_name":"Ezetimibe","level":3,"score":0.8408488631248474},{"id":"https://openalex.org/C2780902209","wikidata":"https://www.wikidata.org/wiki/Q4726914","display_name":"Alirocumab","level":5,"score":0.7720815539360046},{"id":"https://openalex.org/C2778114629","wikidata":"https://www.wikidata.org/wiki/Q15623825","display_name":"Evolocumab","level":5,"score":0.7476432919502258},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.6297854781150818},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.49939441680908203},{"id":"https://openalex.org/C64332521","wikidata":"https://www.wikidata.org/wiki/Q614165","display_name":"Quality-adjusted life year","level":3,"score":0.4827979803085327},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44238877296447754},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4325750172138214},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.16016745567321777},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.06545871496200562},{"id":"https://openalex.org/C2780745583","wikidata":"https://www.wikidata.org/wiki/Q1316030","display_name":"Apolipoprotein A1","level":4,"score":0.0},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069438","descriptor_name":"Ezetimibe","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000071449","descriptor_name":"Proprotein Convertase 9","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1007/s10557-021-07310-y","doi":"https://doi.org/10.1007/s10557-021-07310-y","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10557-021-07310-y","pdf_url":"https://link.springer.com/content/pdf/10.1007/s10557-021-07310-y.pdf","source":{"id":"https://openalex.org/S131791641","display_name":"Cardiovascular Drugs and Therapy","issn_l":"0920-3206","issn":["0920-3206","1573-7241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Drugs and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10397126","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10397126","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10397126/pdf/10557_2021_Article_7310.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovasc Drugs Ther","raw_type":"Text"},{"id":"pmid:35015186","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35015186","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular drugs and therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s10557-021-07310-y","doi":"https://doi.org/10.1007/s10557-021-07310-y","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10557-021-07310-y","pdf_url":"https://link.springer.com/content/pdf/10.1007/s10557-021-07310-y.pdf","source":{"id":"https://openalex.org/S131791641","display_name":"Cardiovascular Drugs and Therapy","issn_l":"0920-3206","issn":["0920-3206","1573-7241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Drugs and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4205437420.pdf","grobid_xml":"https://content.openalex.org/works/W4205437420.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W14563832","https://openalex.org/W168305058","https://openalex.org/W189716308","https://openalex.org/W1520609538","https://openalex.org/W1856460279","https://openalex.org/W2067652305","https://openalex.org/W2084267118","https://openalex.org/W2142347023","https://openalex.org/W2152439558","https://openalex.org/W2164324917","https://openalex.org/W2166752139","https://openalex.org/W2511907480","https://openalex.org/W2596179513","https://openalex.org/W2607159805","https://openalex.org/W2625493639","https://openalex.org/W2749633431","https://openalex.org/W2766166596","https://openalex.org/W2787086160","https://openalex.org/W2789481148","https://openalex.org/W2796750234","https://openalex.org/W2809856630","https://openalex.org/W2899669642","https://openalex.org/W2899997727","https://openalex.org/W2901156820","https://openalex.org/W2906853807","https://openalex.org/W2948233520","https://openalex.org/W2953554798","https://openalex.org/W2953804067","https://openalex.org/W2955835879","https://openalex.org/W2998804962","https://openalex.org/W2998868303","https://openalex.org/W3010882329","https://openalex.org/W3021163647","https://openalex.org/W3111116262","https://openalex.org/W3168744603","https://openalex.org/W3179255618","https://openalex.org/W3183857127","https://openalex.org/W7037711988"],"related_works":["https://openalex.org/W6903533912","https://openalex.org/W4285077730","https://openalex.org/W4306254299","https://openalex.org/W4306319938","https://openalex.org/W2998804962","https://openalex.org/W2787086160","https://openalex.org/W178477505","https://openalex.org/W2607200544","https://openalex.org/W2154636208","https://openalex.org/W2995607476"],"abstract_inverted_index":{"PURPOSE:":[0],"Novel":[1],"pharmaceutical":[2],"treatments":[3],"reducing":[4],"cardiovascular":[5,42,60,92,229],"events":[6,93],"in":[7],"dyslipidaemia":[8],"patients":[9],"must":[10],"demonstrate":[11],"clinical":[12],"efficacy":[13],"and":[14,23,40,54,76,80,131,141,170,176,185,192,198,216,222,256],"cost-effectiveness":[15,29,107,207],"to":[16,34,126,156,246],"promote":[17],"long-term":[18],"adoption":[19],"by":[20],"patients,":[21],"physicians,":[22],"insurers.":[24],"OBJECTIVE:":[25],"To":[26],"assess":[27],"the":[28,45,105,121,152],"of":[30,47,89,123,154,163,190,206,234,243],"statin":[31,64,127,157,238,247],"monotherapy":[32],"compared":[33,245],"additive":[35],"lipid-lowering":[36],"therapies":[37],"for":[38,63,194,212,220,224],"primary":[39,119,228],"secondary":[41,150,217,250],"prevention":[43],"from":[44,59,84],"perspective":[46],"Germany's":[48],"healthcare":[49],"system.":[50],"METHODS:":[51],"Transition":[52],"probabilities":[53],"hazard":[55],"ratios":[56,108],"were":[57,82,104],"derived":[58],"outcome":[61],"trials":[62],"combinations":[65],"with":[66,96],"icosapent":[67,124,171,213,235,252],"ethyl":[68,125,172,214,236],"(REDUCE-IT),":[69],"evolocumab":[70,195],"(FOURIER),":[71],"alirocumab":[72,199,257],"(ODYSSEY),":[73],"ezetimibe":[74,155],"(IMPROVE-IT),":[75],"fibrate":[77],"(ACCORD).":[78],"Costs":[79],"utilities":[81],"retrieved":[83],"previous":[85],"literature.":[86],"The":[87,101],"incidence":[88],"major":[90],"adverse":[91],"was":[94,208],"simulated":[95],"a":[97,231,240],"Markov":[98],"cohort":[99],"model.":[100],"main":[102],"outcomes":[103],"incremental":[106],"(ICER)":[109],"per":[110],"quality":[111],"adjusted":[112],"life":[113],"year":[114],"(QALY)":[115],"gained.":[116],"RESULTS:":[117],"For":[118,149,227,249],"prevention,":[120,151,230,251],"addition":[122,153],"generated":[128],"0.81":[129],"QALY":[130,140,160,175,187],"\u20ac14,732":[132],"costs":[133,145,178,189],"(ICER:":[134,146,167,179,196,200],"18,133),":[135],"whereas":[136],"fibrates":[137],"yielded":[138,173],"0.63":[139],"\u20ac":[142,164],"-":[143,147,165,168],"10,516":[144],"16,632).":[148],"provided":[158],"0.61":[159],"at":[161,188,210,261],"savings":[162],"5,796":[166],"9,555)":[169],"0.99":[174],"\u20ac14,333":[177],"14,485).":[180],"PCSK9":[181],"inhibitors":[182],"offered":[183],"0.55":[184],"0.87":[186],"\u20ac62,722":[191],"\u20ac87,002":[193],"114,639)":[197],"100,532),":[201],"respectively.":[202],"A":[203],"95%":[204],"probability":[205],"surpassed":[209],"\u20ac20,000":[211],"(primary":[215],"prevention),":[218],"\u20ac119,000":[219],"alirocumab,":[221],"\u20ac149,000":[223],"evolocumab.":[225],"CONCLUSIONS:":[226],"combination":[232],"therapy":[233],"plus":[237],"is":[239],"cost-effective":[241],"use":[242],"resources":[244],"monotherapy.":[248],"ethyl,":[253],"ezetimibe,":[254],"evolocumab,":[255],"increase":[258],"patient":[259],"benefit":[260],"different":[262],"economic":[263],"costs.":[264]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4205437420","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2022-01-26T00:00:00"}
